<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37081184</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Nationwide analysis of adult hospitalizations with hemophagocytic lymphohistiocytosis and systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>2091</StartPage><EndPage>2095</EndPage><MedlinePgn>2091-2095</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06594-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Hemophagocytic lymphohistiocytosis (HLH) is a well-recognized complication of systemic lupus erythematosus (SLE). This study aims to characterize HLH with and without SLE in the US adult inpatient population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective study of HLH with and without SLE from the 2016-2019 National Inpatient Sample (NIS) database. We described the demographic characteristics of HLH with and without SLE. Multivariable analysis was performed to calculate odds ratios (OR) for in-hospital death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 8690 hospitalizations had HLH. Of those 605 (7%) had SLE, and 8085 (93%) did not have SLE. Relative to the non-SLE group, the SLE group was younger, had more females, less whites, more African Americans, more Hispanics, and more Asian/Pacific Islanders. Over 60% of HLH with or without SLE had a concurrent infection. Sixty (9.9%) of HLH hospitalizations with SLE died compared to 1735 (21.5%) of those without SLE. Among HLH hospitalizations, multivariable analysis showed that age (OR 1.02; 95% C.I. 1.016-1.031), Charlson Comorbidity Index (OR 1.15; 95% C.I. 1.091-1.213), infections (OR 3.35; 95% C.I. 2.467-4.557), and leukemia/lymphoma (OR 1.46; 95% C.I. 1.112-1.905) had higher odds of in-hospital death. SLE did not increase the odds of death.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Inpatients with both HLH and SLE were younger, had a higher proportion of racial/ethnic minorities, and were predominately female. One out of every 10 hospitalizations for HLH ended in death but SLE itself was not an independent risk factor for death. Concurrent infection was the variable most associated with HLH death. Key Points &#x2022; HLH and SLE group were younger and had higher proportions of female and racial/ethnic minorities. &#x2022; SLE was not an independent risk factor for death in HLH patients.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noboa</LastName><ForeName>Maria Emilia Romero</ForeName><Initials>MER</Initials><Identifier Source="ORCID">0000-0002-3317-3122</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Cook County Hospital, 1950 W. Polk, Chicago, IL, 60612, USA. maria.romero@cookcountyhealth.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Arevalo</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7501-929X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Cook County Hospital, 1950 W. Polk, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Axi R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cook County Hospital, 1950 W. Polk, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Shilpa</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4744-1615</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Cook County Hospital, 1950 W. Polk, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Rush University Medical Center, 1611 West Harrison Street, Suite 510, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manadan</LastName><ForeName>Augustine M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-6200-5139</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Cook County Hospital, 1950 W. Polk, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Rush University Medical Center, 1611 West Harrison Street, Suite 510, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051359" MajorTopicYN="Y">Lymphohistiocytosis, Hemophagocytic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hemophagocytic lymphohistiocytosis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37081184</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06594-9</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06594-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lorenz G, Schul L, Schraml F et al (2020) Adult macrophage activation syndrome haemophagocytic lymphohistiocytosis: &#x201c;of plasma exchange and immunosuppressive escalation strategies&#x201d; - a single centre reflection. Lupus 29:324&#x2013;333. https://doi.org/10.1177/0961203320901594</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320901594</ArticleId><ArticleId IdType="pubmed">32013725</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgia RE, Gerstein M, Levy DM et al (2018) Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ) 70:616&#x2013;624. https://doi.org/10.1002/art.40417</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40417</ArticleId></ArticleIdList></Reference><Reference><Citation>Dall&#x2019;Ara F, Cavazzana I, Frassi M et al (2018) Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center. Reumatismo 70:100&#x2013;105. https://doi.org/10.4081/reumatismo.2018.1023</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/reumatismo.2018.1023</ArticleId><ArticleId IdType="pubmed">29976044</ArticleId></ArticleIdList></Reference><Reference><Citation>Henter JI, Aric&#xf2; M, Egeler RM et al (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28:342&#x2013;347. https://doi.org/10.1002/(sici)1096-911x(199705)28:5%3c342::aid-mpo3%3e3.0.co;2-h</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1096-911x(199705)28:5&lt;342::aid-mpo3&gt;3.0.co;2-h</ArticleId><ArticleId IdType="pubmed">9121398</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AR, Desai PV, Banskota SU et al (2022) Hemophagocytic lymphohistiocytosis hospitalizations in adults and its association with rheumatologic diseases: data from nationwide inpatient sample. J Clin Rheumatol 28:e171&#x2013;e174. https://doi.org/10.1097/RHU.0000000000001670</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000001670</ArticleId><ArticleId IdType="pubmed">33337810</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L-W, Wei JC-C, Chen D-Y et al (2022) Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study. Rheumatology (Oxford) 61:1123&#x2013;1132. https://doi.org/10.1093/rheumatology/keab502</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab502</ArticleId><ArticleId IdType="pubmed">34146089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavand P-E, Serio I, Arnaud L et al (2017) Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev 16:743&#x2013;749. https://doi.org/10.1016/j.autrev.2017.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.05.010</ArticleId><ArticleId IdType="pubmed">28483541</ArticleId></ArticleIdList></Reference><Reference><Citation>Li NL, Kang R, Ardoin SP, Ayoub I (2021) Hemophagocytic lymphohistiocytosis, a rare presentation in lupus nephritis. Kidney Int Rep 6:842&#x2013;845</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2020.11.036</ArticleId><ArticleId IdType="pubmed">33733000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumakura S, Murakawa Y (2014) Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol (Hoboken, NJ) 66:2297&#x2013;2307. https://doi.org/10.1002/art.38672</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38672</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz A, Castaneda EE, Ahmad N et al (2021) Exploring macrophage activation syndrome secondary to systemic lupus erythematosus in adults: a systematic review of the literature. Cureus 13:e18822. https://doi.org/10.7759/cureus.18822</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18822</ArticleId><ArticleId IdType="pubmed">34804679</ArticleId><ArticleId IdType="pmc">8592789</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi A, Dav&#xec; S, Pringe AB et al (2009) Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60:3388&#x2013;3399. https://doi.org/10.1002/art.24883</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24883</ArticleId><ArticleId IdType="pubmed">19877067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KF, Hui PK, Chan JK et al (1991) The acute lupus hemophagocytic syndrome. Ann Intern Med 114:387&#x2013;390. https://doi.org/10.7326/0003-4819-114-5-387</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-114-5-387</ArticleId><ArticleId IdType="pubmed">1992881</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukaya S, Yasuda S, Hashimoto T et al (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47:1686&#x2013;1691. https://doi.org/10.1093/rheumatology/ken342</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken342</ArticleId><ArticleId IdType="pubmed">18782855</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveen R, Jain A, Muhammed H et al (2021) Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities. Rheumatol Int 41:625&#x2013;631. https://doi.org/10.1007/s00296-020-04763-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04763-6</ArticleId><ArticleId IdType="pubmed">33388903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M, Brito-Zer&#xf3;n P, L&#xf3;pez-Guillermo A et al (2014) Adult haemophagocytic syndrome. Lancet (London, England) 383:1503&#x2013;1516. https://doi.org/10.1016/S0140-6736(13)61048-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61048-X</ArticleId><ArticleId IdType="pubmed">24290661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>